盆腔肿瘤放化疗与骨髓抑制相关性的研究进展
DOI:
作者:
作者单位:

1.吉首大学医学院;2.湖南省常德市第一人民医院肿瘤科

作者简介:

通讯作者:

中图分类号:

基金项目:

基金项目:湖南省科技创新计划项目(2020SSK50204),常德市科学技术局技术研究与开发资金项目(2019S165)


Research progress of the correlation between radiotherapy and chemotherapy and bone marrow suppression in pelvic tumors
Author:
Affiliation:

1.Jishou University of Medicine Department of Medical Oncology,The First People’s Hosital of Changde City;2..Department of Medical Oncology, The First People’s Hosital of Changde City;3.Department of Medical Oncology, The First People’s Hosital of Changde City

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    骨髓抑制风险识别是肿瘤放化疗治疗中需要解决的一个重要问题,本文从放疗技术、放疗剂量学参数和化疗方案等方面对国内外肿瘤放化疗与骨髓抑制相关性的研究现状进行综述,为构建我国骨髓抑制预测模型提供参考,以便早期识别高危人群,进行针对性预防和治疗。

    Abstract:

    Bone marrow suppression risk identification are the important issues that need to be solved in the tumor radiation and chemotherapy treatment. This paper reviewed the research status of the correlation between radiotherapy and chemotherapy and bone marrow suppression in pelvic tumors at home and abroad from the aspects of radiotherapy technology, radiotherapy dosimetry parameters, chemotherapy regimens and so on. We aimed to provide reference for the construction of a prediction model of bone marrow suppression in our country, in order to identify high-risk groups early, formulate prevention and treatment.

    参考文献
    相似文献
    引证文献
引用本文

汤婷,肖泽民,田伟,黄大元,杜阳峰.盆腔肿瘤放化疗与骨髓抑制相关性的研究进展[J].生物医学工程学进展,2022,(4):238-245

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-11-22
  • 最后修改日期:2022-12-29
  • 录用日期:2022-11-23
  • 在线发布日期: 2023-02-10
  • 出版日期:
二维码